Table 3 Multivariate analysis for factor associated with uncontrolled hyperlipidemia among T2D patients with clinical ASCVD
Factors | LDL-C level (mg/dL) | Adjusted Odds Ratio | 95% CI | p-value | |
|---|---|---|---|---|---|
≥ 70 | < 70 | ||||
n (%) | n (%) | ||||
Gender | |||||
Male | 521 (76.1) | 164 (23.9) | 1.0 | ||
Female | 695 (82.5) | 147 (17.5) | 1.5 | 1.2–2.0 | 0.002 |
Hospital level | |||||
Standard/advanced hospital | 1168 (79.3) | 305 (20.7) | 1.0 | ||
Community hospital | 48 (88.9) | 6 (11.1) | 4.3 | 1.0–18.0 | 0.048 |
Thiazolidinedione | |||||
No | 1061 (78.8) | 286 (21.2) | 1.0 | ||
Yes | 155 (86.1) | 25 (13.9) | 1.7 | 1.1–2.7 | 0.024 |
BMI (kg/m2) | |||||
< 18.5 | 42 (65.6) | 22 (34.4) | 1.0 | ||
18.5–22.9 | 310 (80.5) | 75 (19.5) | 2.2 | 1.2–4.0 | 0.016 |
23.0–24.9 | 222 (75.5) | 72 (24.5) | 1.8 | 0.9–3.3 | 0.074 |
25.0–29.9 | 412 (81.6) | 93 (18.4) | 2.3 | 1.3–4.3 | 0.007 |
≥ 30.0 | 201 (83.8) | 39 (16.3) | 2.5 | 1.3–4.9 | 0.007 |